Search results for: 'astrazeneca'
-
Global Big Pharma Partnering Terms and Agreements 2016-2023March 2023$3,995.00
Provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals
Learn More -
Medical Device Collaboration and Licensing Deals 2016-2024May 2024$3,995.00
Medical Device Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Global Biotech Partnering Terms and Agreements 2018-2023March 2023$3,995.00
Global Biotech Partnering Terms and Agreements 2018 to 2023 report provides a detailed understanding and analysis of how and why companies enter biotech partnering deals.
Learn More -
Global Pharmaceutical Partnering Terms and Agreements 2018-2023March 2023$3,995.00
Global Pharmaceutical Partnering Terms and Agreements 2018 to 2023 report provides a detailed understanding and analysis of how and why companies enter pharmaceutical partnering deals.
Learn More -
Global Academic and Non-Profit Partnering Terms and Agreements 2016-2023March 2023$3,995.00
Global Academic and Non-Profit Partnering Terms and Agreements 2016 to 2023 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals.
Learn More -
Global Specialty Pharmaceutical Partnering Terms and Agreements 2016-2023March 2023$3,995.00
Global Specialty Pharmaceutical Partnering Terms and Agreements 2016 to 2023 report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals.
Learn More -
Diagnostic Collaboration and Licensing Deals 2019-2024May 2024$3,995.00
Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More